Clinical Trial Update: Three Times Weekly (TIW) Growth Hormone Therapy in Children on Hemodialysis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating three-times-weekly growth hormone therapy in children on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Kidney Failure, Chronic, Renal Dialysis | Phase 3 | Status: COMPLETED